UFP Technologies, Inc. (UFPT)
NASDAQ: UFPT · Real-Time Price · USD
226.35
-10.29 (-4.35%)
At close: May 28, 2025, 4:00 PM
228.94
+2.59 (1.14%)
After-hours: May 28, 2025, 4:00 PM EDT
UFP Technologies Market Cap
UFP Technologies has a market cap or net worth of $1.74 billion as of May 28, 2025. Its market cap has decreased by -12.68% in one year.
Market Cap
1.74B
Enterprise Value
1.93B
1-Year Change
-12.68%
Ranking
Category
Stock Price
$226.35
Market Cap Chart
Since December 1, 1998, UFP Technologies's market cap has increased from $15.40M to $1.74B, an increase of 11,227.53%. That is a compound annual growth rate of 19.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 27, 2025 | 1.82B | -2.81% |
Dec 31, 2024 | 1.88B | 42.79% |
Dec 29, 2023 | 1.31B | 47.10% |
Dec 30, 2022 | 893.40M | 68.82% |
Dec 31, 2021 | 529.20M | 51.50% |
Dec 31, 2020 | 349.30M | -5.34% |
Dec 31, 2019 | 369.00M | 66.59% |
Dec 31, 2018 | 221.50M | 9.65% |
Dec 29, 2017 | 202.00M | 9.78% |
Dec 30, 2016 | 184.00M | 8.24% |
Dec 31, 2015 | 170.00M | -2.02% |
Dec 31, 2014 | 173.50M | -0.12% |
Dec 31, 2013 | 173.70M | 44.03% |
Dec 31, 2012 | 120.60M | 25.10% |
Dec 30, 2011 | 96.40M | 27.18% |
Dec 31, 2010 | 75.80M | 96.88% |
Dec 31, 2009 | 38.50M | 29.19% |
Dec 31, 2008 | 29.80M | -24.56% |
Dec 31, 2007 | 39.50M | 36.68% |
Dec 29, 2006 | 28.90M | 153.51% |
Dec 30, 2005 | 11.40M | -35.23% |
Dec 31, 2004 | 17.60M | 100.00% |
Dec 31, 2003 | 8.80M | 95.56% |
Dec 31, 2002 | 4.50M | - |
Dec 31, 2001 | 4.50M | -39.19% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 650.79B |
Johnson & Johnson | 368.06B |
AbbVie | 328.00B |
Novo Nordisk | 313.75B |
UnitedHealth Group | 270.78B |
Abbott Laboratories | 232.01B |
Novartis AG | 221.98B |
AstraZeneca | 219.74B |